Global Liposomal Drug-delivery System Market Research Report 2024(Status and Outlook)
Report Overview:
Liposomal Drug-delivery System is a pharmaceutical technology that encapsulates drugs within lipid-based vesicles called liposomes. These microscopic structures enhance the delivery of drugs to target tissues, improve drug stability, and control drug release rates. Liposomal drug delivery is used to enhance the therapeutic effects of medications, reduce side effects, and improve the solubility of poorly water-soluble drugs.
The Global Liposomal Drug-delivery System Market Size was estimated at USD 3658.65 million in 2023 and is projected to reach USD 6516.96 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Liposomal Drug-delivery System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liposomal Drug-delivery System Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liposomal Drug-delivery System market in any manner.
Global Liposomal Drug-delivery System Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Market Segmentation (by Type)
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Market Segmentation (by Application)
Medical
Cosmetics
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liposomal Drug-delivery System Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Liposomal Drug-delivery System is a pharmaceutical technology that encapsulates drugs within lipid-based vesicles called liposomes. These microscopic structures enhance the delivery of drugs to target tissues, improve drug stability, and control drug release rates. Liposomal drug delivery is used to enhance the therapeutic effects of medications, reduce side effects, and improve the solubility of poorly water-soluble drugs.
The Global Liposomal Drug-delivery System Market Size was estimated at USD 3658.65 million in 2023 and is projected to reach USD 6516.96 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Liposomal Drug-delivery System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liposomal Drug-delivery System Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liposomal Drug-delivery System market in any manner.
Global Liposomal Drug-delivery System Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Market Segmentation (by Type)
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Market Segmentation (by Application)
Medical
Cosmetics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Liposomal Drug-delivery System Market
- Overview of the regional outlook of the Liposomal Drug-delivery System Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liposomal Drug-delivery System Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Liposomal Drug-delivery System
1.2 Key Market Segments
1.2.1 Liposomal Drug-delivery System Segment by Type
1.2.2 Liposomal Drug-delivery System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Liposomal Drug-delivery System Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Liposomal Drug-delivery System Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET COMPETITIVE LANDSCAPE
3.1 Global Liposomal Drug-delivery System Sales by Manufacturers (2019-2024)
3.2 Global Liposomal Drug-delivery System Revenue Market Share by Manufacturers (2019-2024)
3.3 Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liposomal Drug-delivery System Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Liposomal Drug-delivery System Sales Sites, Area Served, Product Type
3.6 Liposomal Drug-delivery System Market Competitive Situation and Trends
3.6.1 Liposomal Drug-delivery System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liposomal Drug-delivery System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIPOSOMAL DRUG-DELIVERY SYSTEM INDUSTRY CHAIN ANALYSIS
4.1 Liposomal Drug-delivery System Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liposomal Drug-delivery System Sales Market Share by Type (2019-2024)
6.3 Global Liposomal Drug-delivery System Market Size Market Share by Type (2019-2024)
6.4 Global Liposomal Drug-delivery System Price by Type (2019-2024)
7 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liposomal Drug-delivery System Market Sales by Application (2019-2024)
7.3 Global Liposomal Drug-delivery System Market Size (M USD) by Application (2019-2024)
7.4 Global Liposomal Drug-delivery System Sales Growth Rate by Application (2019-2024)
8 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY REGION
8.1 Global Liposomal Drug-delivery System Sales by Region
8.1.1 Global Liposomal Drug-delivery System Sales by Region
8.1.2 Global Liposomal Drug-delivery System Sales Market Share by Region
8.2 North America
8.2.1 North America Liposomal Drug-delivery System Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liposomal Drug-delivery System Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liposomal Drug-delivery System Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liposomal Drug-delivery System Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liposomal Drug-delivery System Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lipoid Kosmetik
9.1.1 Lipoid Kosmetik Liposomal Drug-delivery System Basic Information
9.1.2 Lipoid Kosmetik Liposomal Drug-delivery System Product Overview
9.1.3 Lipoid Kosmetik Liposomal Drug-delivery System Product Market Performance
9.1.4 Lipoid Kosmetik Business Overview
9.1.5 Lipoid Kosmetik Liposomal Drug-delivery System SWOT Analysis
9.1.6 Lipoid Kosmetik Recent Developments
9.2 Lucas Meyer Cosmetics
9.2.1 Lucas Meyer Cosmetics Liposomal Drug-delivery System Basic Information
9.2.2 Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Overview
9.2.3 Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Market Performance
9.2.4 Lucas Meyer Cosmetics Business Overview
9.2.5 Lucas Meyer Cosmetics Liposomal Drug-delivery System SWOT Analysis
9.2.6 Lucas Meyer Cosmetics Recent Developments
9.3 Nippon Fine Chemical
9.3.1 Nippon Fine Chemical Liposomal Drug-delivery System Basic Information
9.3.2 Nippon Fine Chemical Liposomal Drug-delivery System Product Overview
9.3.3 Nippon Fine Chemical Liposomal Drug-delivery System Product Market Performance
9.3.4 Nippon Fine Chemical Liposomal Drug-delivery System SWOT Analysis
9.3.5 Nippon Fine Chemical Business Overview
9.3.6 Nippon Fine Chemical Recent Developments
9.4 Enoc Solutions
9.4.1 Enoc Solutions Liposomal Drug-delivery System Basic Information
9.4.2 Enoc Solutions Liposomal Drug-delivery System Product Overview
9.4.3 Enoc Solutions Liposomal Drug-delivery System Product Market Performance
9.4.4 Enoc Solutions Business Overview
9.4.5 Enoc Solutions Recent Developments
9.5 Nanovec
9.5.1 Nanovec Liposomal Drug-delivery System Basic Information
9.5.2 Nanovec Liposomal Drug-delivery System Product Overview
9.5.3 Nanovec Liposomal Drug-delivery System Product Market Performance
9.5.4 Nanovec Business Overview
9.5.5 Nanovec Recent Developments
9.6 Lipotec
9.6.1 Lipotec Liposomal Drug-delivery System Basic Information
9.6.2 Lipotec Liposomal Drug-delivery System Product Overview
9.6.3 Lipotec Liposomal Drug-delivery System Product Market Performance
9.6.4 Lipotec Business Overview
9.6.5 Lipotec Recent Developments
9.7 Croda
9.7.1 Croda Liposomal Drug-delivery System Basic Information
9.7.2 Croda Liposomal Drug-delivery System Product Overview
9.7.3 Croda Liposomal Drug-delivery System Product Market Performance
9.7.4 Croda Business Overview
9.7.5 Croda Recent Developments
9.8 HandA Pharmachem
9.8.1 HandA Pharmachem Liposomal Drug-delivery System Basic Information
9.8.2 HandA Pharmachem Liposomal Drug-delivery System Product Overview
9.8.3 HandA Pharmachem Liposomal Drug-delivery System Product Market Performance
9.8.4 HandA Pharmachem Business Overview
9.8.5 HandA Pharmachem Recent Developments
9.9 Lipomize
9.9.1 Lipomize Liposomal Drug-delivery System Basic Information
9.9.2 Lipomize Liposomal Drug-delivery System Product Overview
9.9.3 Lipomize Liposomal Drug-delivery System Product Market Performance
9.9.4 Lipomize Business Overview
9.9.5 Lipomize Recent Developments
9.10 ID bio
9.10.1 ID bio Liposomal Drug-delivery System Basic Information
9.10.2 ID bio Liposomal Drug-delivery System Product Overview
9.10.3 ID bio Liposomal Drug-delivery System Product Market Performance
9.10.4 ID bio Business Overview
9.10.5 ID bio Recent Developments
9.11 BioSpectrum
9.11.1 BioSpectrum Liposomal Drug-delivery System Basic Information
9.11.2 BioSpectrum Liposomal Drug-delivery System Product Overview
9.11.3 BioSpectrum Liposomal Drug-delivery System Product Market Performance
9.11.4 BioSpectrum Business Overview
9.11.5 BioSpectrum Recent Developments
9.12 Derma Clinical
9.12.1 Derma Clinical Liposomal Drug-delivery System Basic Information
9.12.2 Derma Clinical Liposomal Drug-delivery System Product Overview
9.12.3 Derma Clinical Liposomal Drug-delivery System Product Market Performance
9.12.4 Derma Clinical Business Overview
9.12.5 Derma Clinical Recent Developments
9.13 Kewpie Corporation
9.13.1 Kewpie Corporation Liposomal Drug-delivery System Basic Information
9.13.2 Kewpie Corporation Liposomal Drug-delivery System Product Overview
9.13.3 Kewpie Corporation Liposomal Drug-delivery System Product Market Performance
9.13.4 Kewpie Corporation Business Overview
9.13.5 Kewpie Corporation Recent Developments
9.14 Nanohealth Biotech
9.14.1 Nanohealth Biotech Liposomal Drug-delivery System Basic Information
9.14.2 Nanohealth Biotech Liposomal Drug-delivery System Product Overview
9.14.3 Nanohealth Biotech Liposomal Drug-delivery System Product Market Performance
9.14.4 Nanohealth Biotech Business Overview
9.14.5 Nanohealth Biotech Recent Developments
9.15 Creative Biostructure
9.15.1 Creative Biostructure Liposomal Drug-delivery System Basic Information
9.15.2 Creative Biostructure Liposomal Drug-delivery System Product Overview
9.15.3 Creative Biostructure Liposomal Drug-delivery System Product Market Performance
9.15.4 Creative Biostructure Business Overview
9.15.5 Creative Biostructure Recent Developments
9.16 Phenbiox
9.16.1 Phenbiox Liposomal Drug-delivery System Basic Information
9.16.2 Phenbiox Liposomal Drug-delivery System Product Overview
9.16.3 Phenbiox Liposomal Drug-delivery System Product Market Performance
9.16.4 Phenbiox Business Overview
9.16.5 Phenbiox Recent Developments
9.17 NOF CORPORATION
9.17.1 NOF CORPORATION Liposomal Drug-delivery System Basic Information
9.17.2 NOF CORPORATION Liposomal Drug-delivery System Product Overview
9.17.3 NOF CORPORATION Liposomal Drug-delivery System Product Market Performance
9.17.4 NOF CORPORATION Business Overview
9.17.5 NOF CORPORATION Recent Developments
9.18 KYOWA PHARMA CHEMICAL
9.18.1 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Basic Information
9.18.2 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Overview
9.18.3 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Market Performance
9.18.4 KYOWA PHARMA CHEMICAL Business Overview
9.18.5 KYOWA PHARMA CHEMICAL Recent Developments
9.19 Nikko Chemicals
9.19.1 Nikko Chemicals Liposomal Drug-delivery System Basic Information
9.19.2 Nikko Chemicals Liposomal Drug-delivery System Product Overview
9.19.3 Nikko Chemicals Liposomal Drug-delivery System Product Market Performance
9.19.4 Nikko Chemicals Business Overview
9.19.5 Nikko Chemicals Recent Developments
10 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET FORECAST BY REGION
10.1 Global Liposomal Drug-delivery System Market Size Forecast
10.2 Global Liposomal Drug-delivery System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liposomal Drug-delivery System Market Size Forecast by Country
10.2.3 Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Region
10.2.4 South America Liposomal Drug-delivery System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liposomal Drug-delivery System by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Liposomal Drug-delivery System Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Liposomal Drug-delivery System by Type (2025-2030)
11.1.2 Global Liposomal Drug-delivery System Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Liposomal Drug-delivery System by Type (2025-2030)
11.2 Global Liposomal Drug-delivery System Market Forecast by Application (2025-2030)
11.2.1 Global Liposomal Drug-delivery System Sales (Kilotons) Forecast by Application
11.2.2 Global Liposomal Drug-delivery System Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Liposomal Drug-delivery System
1.2 Key Market Segments
1.2.1 Liposomal Drug-delivery System Segment by Type
1.2.2 Liposomal Drug-delivery System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Liposomal Drug-delivery System Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Liposomal Drug-delivery System Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET COMPETITIVE LANDSCAPE
3.1 Global Liposomal Drug-delivery System Sales by Manufacturers (2019-2024)
3.2 Global Liposomal Drug-delivery System Revenue Market Share by Manufacturers (2019-2024)
3.3 Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liposomal Drug-delivery System Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Liposomal Drug-delivery System Sales Sites, Area Served, Product Type
3.6 Liposomal Drug-delivery System Market Competitive Situation and Trends
3.6.1 Liposomal Drug-delivery System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liposomal Drug-delivery System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIPOSOMAL DRUG-DELIVERY SYSTEM INDUSTRY CHAIN ANALYSIS
4.1 Liposomal Drug-delivery System Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liposomal Drug-delivery System Sales Market Share by Type (2019-2024)
6.3 Global Liposomal Drug-delivery System Market Size Market Share by Type (2019-2024)
6.4 Global Liposomal Drug-delivery System Price by Type (2019-2024)
7 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liposomal Drug-delivery System Market Sales by Application (2019-2024)
7.3 Global Liposomal Drug-delivery System Market Size (M USD) by Application (2019-2024)
7.4 Global Liposomal Drug-delivery System Sales Growth Rate by Application (2019-2024)
8 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET SEGMENTATION BY REGION
8.1 Global Liposomal Drug-delivery System Sales by Region
8.1.1 Global Liposomal Drug-delivery System Sales by Region
8.1.2 Global Liposomal Drug-delivery System Sales Market Share by Region
8.2 North America
8.2.1 North America Liposomal Drug-delivery System Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liposomal Drug-delivery System Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liposomal Drug-delivery System Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liposomal Drug-delivery System Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liposomal Drug-delivery System Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lipoid Kosmetik
9.1.1 Lipoid Kosmetik Liposomal Drug-delivery System Basic Information
9.1.2 Lipoid Kosmetik Liposomal Drug-delivery System Product Overview
9.1.3 Lipoid Kosmetik Liposomal Drug-delivery System Product Market Performance
9.1.4 Lipoid Kosmetik Business Overview
9.1.5 Lipoid Kosmetik Liposomal Drug-delivery System SWOT Analysis
9.1.6 Lipoid Kosmetik Recent Developments
9.2 Lucas Meyer Cosmetics
9.2.1 Lucas Meyer Cosmetics Liposomal Drug-delivery System Basic Information
9.2.2 Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Overview
9.2.3 Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Market Performance
9.2.4 Lucas Meyer Cosmetics Business Overview
9.2.5 Lucas Meyer Cosmetics Liposomal Drug-delivery System SWOT Analysis
9.2.6 Lucas Meyer Cosmetics Recent Developments
9.3 Nippon Fine Chemical
9.3.1 Nippon Fine Chemical Liposomal Drug-delivery System Basic Information
9.3.2 Nippon Fine Chemical Liposomal Drug-delivery System Product Overview
9.3.3 Nippon Fine Chemical Liposomal Drug-delivery System Product Market Performance
9.3.4 Nippon Fine Chemical Liposomal Drug-delivery System SWOT Analysis
9.3.5 Nippon Fine Chemical Business Overview
9.3.6 Nippon Fine Chemical Recent Developments
9.4 Enoc Solutions
9.4.1 Enoc Solutions Liposomal Drug-delivery System Basic Information
9.4.2 Enoc Solutions Liposomal Drug-delivery System Product Overview
9.4.3 Enoc Solutions Liposomal Drug-delivery System Product Market Performance
9.4.4 Enoc Solutions Business Overview
9.4.5 Enoc Solutions Recent Developments
9.5 Nanovec
9.5.1 Nanovec Liposomal Drug-delivery System Basic Information
9.5.2 Nanovec Liposomal Drug-delivery System Product Overview
9.5.3 Nanovec Liposomal Drug-delivery System Product Market Performance
9.5.4 Nanovec Business Overview
9.5.5 Nanovec Recent Developments
9.6 Lipotec
9.6.1 Lipotec Liposomal Drug-delivery System Basic Information
9.6.2 Lipotec Liposomal Drug-delivery System Product Overview
9.6.3 Lipotec Liposomal Drug-delivery System Product Market Performance
9.6.4 Lipotec Business Overview
9.6.5 Lipotec Recent Developments
9.7 Croda
9.7.1 Croda Liposomal Drug-delivery System Basic Information
9.7.2 Croda Liposomal Drug-delivery System Product Overview
9.7.3 Croda Liposomal Drug-delivery System Product Market Performance
9.7.4 Croda Business Overview
9.7.5 Croda Recent Developments
9.8 HandA Pharmachem
9.8.1 HandA Pharmachem Liposomal Drug-delivery System Basic Information
9.8.2 HandA Pharmachem Liposomal Drug-delivery System Product Overview
9.8.3 HandA Pharmachem Liposomal Drug-delivery System Product Market Performance
9.8.4 HandA Pharmachem Business Overview
9.8.5 HandA Pharmachem Recent Developments
9.9 Lipomize
9.9.1 Lipomize Liposomal Drug-delivery System Basic Information
9.9.2 Lipomize Liposomal Drug-delivery System Product Overview
9.9.3 Lipomize Liposomal Drug-delivery System Product Market Performance
9.9.4 Lipomize Business Overview
9.9.5 Lipomize Recent Developments
9.10 ID bio
9.10.1 ID bio Liposomal Drug-delivery System Basic Information
9.10.2 ID bio Liposomal Drug-delivery System Product Overview
9.10.3 ID bio Liposomal Drug-delivery System Product Market Performance
9.10.4 ID bio Business Overview
9.10.5 ID bio Recent Developments
9.11 BioSpectrum
9.11.1 BioSpectrum Liposomal Drug-delivery System Basic Information
9.11.2 BioSpectrum Liposomal Drug-delivery System Product Overview
9.11.3 BioSpectrum Liposomal Drug-delivery System Product Market Performance
9.11.4 BioSpectrum Business Overview
9.11.5 BioSpectrum Recent Developments
9.12 Derma Clinical
9.12.1 Derma Clinical Liposomal Drug-delivery System Basic Information
9.12.2 Derma Clinical Liposomal Drug-delivery System Product Overview
9.12.3 Derma Clinical Liposomal Drug-delivery System Product Market Performance
9.12.4 Derma Clinical Business Overview
9.12.5 Derma Clinical Recent Developments
9.13 Kewpie Corporation
9.13.1 Kewpie Corporation Liposomal Drug-delivery System Basic Information
9.13.2 Kewpie Corporation Liposomal Drug-delivery System Product Overview
9.13.3 Kewpie Corporation Liposomal Drug-delivery System Product Market Performance
9.13.4 Kewpie Corporation Business Overview
9.13.5 Kewpie Corporation Recent Developments
9.14 Nanohealth Biotech
9.14.1 Nanohealth Biotech Liposomal Drug-delivery System Basic Information
9.14.2 Nanohealth Biotech Liposomal Drug-delivery System Product Overview
9.14.3 Nanohealth Biotech Liposomal Drug-delivery System Product Market Performance
9.14.4 Nanohealth Biotech Business Overview
9.14.5 Nanohealth Biotech Recent Developments
9.15 Creative Biostructure
9.15.1 Creative Biostructure Liposomal Drug-delivery System Basic Information
9.15.2 Creative Biostructure Liposomal Drug-delivery System Product Overview
9.15.3 Creative Biostructure Liposomal Drug-delivery System Product Market Performance
9.15.4 Creative Biostructure Business Overview
9.15.5 Creative Biostructure Recent Developments
9.16 Phenbiox
9.16.1 Phenbiox Liposomal Drug-delivery System Basic Information
9.16.2 Phenbiox Liposomal Drug-delivery System Product Overview
9.16.3 Phenbiox Liposomal Drug-delivery System Product Market Performance
9.16.4 Phenbiox Business Overview
9.16.5 Phenbiox Recent Developments
9.17 NOF CORPORATION
9.17.1 NOF CORPORATION Liposomal Drug-delivery System Basic Information
9.17.2 NOF CORPORATION Liposomal Drug-delivery System Product Overview
9.17.3 NOF CORPORATION Liposomal Drug-delivery System Product Market Performance
9.17.4 NOF CORPORATION Business Overview
9.17.5 NOF CORPORATION Recent Developments
9.18 KYOWA PHARMA CHEMICAL
9.18.1 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Basic Information
9.18.2 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Overview
9.18.3 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Market Performance
9.18.4 KYOWA PHARMA CHEMICAL Business Overview
9.18.5 KYOWA PHARMA CHEMICAL Recent Developments
9.19 Nikko Chemicals
9.19.1 Nikko Chemicals Liposomal Drug-delivery System Basic Information
9.19.2 Nikko Chemicals Liposomal Drug-delivery System Product Overview
9.19.3 Nikko Chemicals Liposomal Drug-delivery System Product Market Performance
9.19.4 Nikko Chemicals Business Overview
9.19.5 Nikko Chemicals Recent Developments
10 LIPOSOMAL DRUG-DELIVERY SYSTEM MARKET FORECAST BY REGION
10.1 Global Liposomal Drug-delivery System Market Size Forecast
10.2 Global Liposomal Drug-delivery System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liposomal Drug-delivery System Market Size Forecast by Country
10.2.3 Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Region
10.2.4 South America Liposomal Drug-delivery System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liposomal Drug-delivery System by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Liposomal Drug-delivery System Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Liposomal Drug-delivery System by Type (2025-2030)
11.1.2 Global Liposomal Drug-delivery System Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Liposomal Drug-delivery System by Type (2025-2030)
11.2 Global Liposomal Drug-delivery System Market Forecast by Application (2025-2030)
11.2.1 Global Liposomal Drug-delivery System Sales (Kilotons) Forecast by Application
11.2.2 Global Liposomal Drug-delivery System Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liposomal Drug-delivery System Market Size Comparison by Region (M USD)
Table 5. Global Liposomal Drug-delivery System Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Liposomal Drug-delivery System Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Liposomal Drug-delivery System Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Liposomal Drug-delivery System Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug-delivery System as of 2022)
Table 10. Global Market Liposomal Drug-delivery System Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Liposomal Drug-delivery System Sales Sites and Area Served
Table 12. Manufacturers Liposomal Drug-delivery System Product Type
Table 13. Global Liposomal Drug-delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Liposomal Drug-delivery System
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Liposomal Drug-delivery System Market Challenges
Table 22. Global Liposomal Drug-delivery System Sales by Type (Kilotons)
Table 23. Global Liposomal Drug-delivery System Market Size by Type (M USD)
Table 24. Global Liposomal Drug-delivery System Sales (Kilotons) by Type (2019-2024)
Table 25. Global Liposomal Drug-delivery System Sales Market Share by Type (2019-2024)
Table 26. Global Liposomal Drug-delivery System Market Size (M USD) by Type (2019-2024)
Table 27. Global Liposomal Drug-delivery System Market Size Share by Type (2019-2024)
Table 28. Global Liposomal Drug-delivery System Price (USD/Ton) by Type (2019-2024)
Table 29. Global Liposomal Drug-delivery System Sales (Kilotons) by Application
Table 30. Global Liposomal Drug-delivery System Market Size by Application
Table 31. Global Liposomal Drug-delivery System Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Liposomal Drug-delivery System Sales Market Share by Application (2019-2024)
Table 33. Global Liposomal Drug-delivery System Sales by Application (2019-2024) & (M USD)
Table 34. Global Liposomal Drug-delivery System Market Share by Application (2019-2024)
Table 35. Global Liposomal Drug-delivery System Sales Growth Rate by Application (2019-2024)
Table 36. Global Liposomal Drug-delivery System Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Liposomal Drug-delivery System Sales Market Share by Region (2019-2024)
Table 38. North America Liposomal Drug-delivery System Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Liposomal Drug-delivery System Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Liposomal Drug-delivery System Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Liposomal Drug-delivery System Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Liposomal Drug-delivery System Sales by Region (2019-2024) & (Kilotons)
Table 43. Lipoid Kosmetik Liposomal Drug-delivery System Basic Information
Table 44. Lipoid Kosmetik Liposomal Drug-delivery System Product Overview
Table 45. Lipoid Kosmetik Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Lipoid Kosmetik Business Overview
Table 47. Lipoid Kosmetik Liposomal Drug-delivery System SWOT Analysis
Table 48. Lipoid Kosmetik Recent Developments
Table 49. Lucas Meyer Cosmetics Liposomal Drug-delivery System Basic Information
Table 50. Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Overview
Table 51. Lucas Meyer Cosmetics Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Lucas Meyer Cosmetics Business Overview
Table 53. Lucas Meyer Cosmetics Liposomal Drug-delivery System SWOT Analysis
Table 54. Lucas Meyer Cosmetics Recent Developments
Table 55. Nippon Fine Chemical Liposomal Drug-delivery System Basic Information
Table 56. Nippon Fine Chemical Liposomal Drug-delivery System Product Overview
Table 57. Nippon Fine Chemical Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Nippon Fine Chemical Liposomal Drug-delivery System SWOT Analysis
Table 59. Nippon Fine Chemical Business Overview
Table 60. Nippon Fine Chemical Recent Developments
Table 61. Enoc Solutions Liposomal Drug-delivery System Basic Information
Table 62. Enoc Solutions Liposomal Drug-delivery System Product Overview
Table 63. Enoc Solutions Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Enoc Solutions Business Overview
Table 65. Enoc Solutions Recent Developments
Table 66. Nanovec Liposomal Drug-delivery System Basic Information
Table 67. Nanovec Liposomal Drug-delivery System Product Overview
Table 68. Nanovec Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Nanovec Business Overview
Table 70. Nanovec Recent Developments
Table 71. Lipotec Liposomal Drug-delivery System Basic Information
Table 72. Lipotec Liposomal Drug-delivery System Product Overview
Table 73. Lipotec Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Lipotec Business Overview
Table 75. Lipotec Recent Developments
Table 76. Croda Liposomal Drug-delivery System Basic Information
Table 77. Croda Liposomal Drug-delivery System Product Overview
Table 78. Croda Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Croda Business Overview
Table 80. Croda Recent Developments
Table 81. HandA Pharmachem Liposomal Drug-delivery System Basic Information
Table 82. HandA Pharmachem Liposomal Drug-delivery System Product Overview
Table 83. HandA Pharmachem Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. HandA Pharmachem Business Overview
Table 85. HandA Pharmachem Recent Developments
Table 86. Lipomize Liposomal Drug-delivery System Basic Information
Table 87. Lipomize Liposomal Drug-delivery System Product Overview
Table 88. Lipomize Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lipomize Business Overview
Table 90. Lipomize Recent Developments
Table 91. ID bio Liposomal Drug-delivery System Basic Information
Table 92. ID bio Liposomal Drug-delivery System Product Overview
Table 93. ID bio Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. ID bio Business Overview
Table 95. ID bio Recent Developments
Table 96. BioSpectrum Liposomal Drug-delivery System Basic Information
Table 97. BioSpectrum Liposomal Drug-delivery System Product Overview
Table 98. BioSpectrum Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. BioSpectrum Business Overview
Table 100. BioSpectrum Recent Developments
Table 101. Derma Clinical Liposomal Drug-delivery System Basic Information
Table 102. Derma Clinical Liposomal Drug-delivery System Product Overview
Table 103. Derma Clinical Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Derma Clinical Business Overview
Table 105. Derma Clinical Recent Developments
Table 106. Kewpie Corporation Liposomal Drug-delivery System Basic Information
Table 107. Kewpie Corporation Liposomal Drug-delivery System Product Overview
Table 108. Kewpie Corporation Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Kewpie Corporation Business Overview
Table 110. Kewpie Corporation Recent Developments
Table 111. Nanohealth Biotech Liposomal Drug-delivery System Basic Information
Table 112. Nanohealth Biotech Liposomal Drug-delivery System Product Overview
Table 113. Nanohealth Biotech Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Nanohealth Biotech Business Overview
Table 115. Nanohealth Biotech Recent Developments
Table 116. Creative Biostructure Liposomal Drug-delivery System Basic Information
Table 117. Creative Biostructure Liposomal Drug-delivery System Product Overview
Table 118. Creative Biostructure Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Creative Biostructure Business Overview
Table 120. Creative Biostructure Recent Developments
Table 121. Phenbiox Liposomal Drug-delivery System Basic Information
Table 122. Phenbiox Liposomal Drug-delivery System Product Overview
Table 123. Phenbiox Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Phenbiox Business Overview
Table 125. Phenbiox Recent Developments
Table 126. NOF CORPORATION Liposomal Drug-delivery System Basic Information
Table 127. NOF CORPORATION Liposomal Drug-delivery System Product Overview
Table 128. NOF CORPORATION Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. NOF CORPORATION Business Overview
Table 130. NOF CORPORATION Recent Developments
Table 131. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Basic Information
Table 132. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Overview
Table 133. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. KYOWA PHARMA CHEMICAL Business Overview
Table 135. KYOWA PHARMA CHEMICAL Recent Developments
Table 136. Nikko Chemicals Liposomal Drug-delivery System Basic Information
Table 137. Nikko Chemicals Liposomal Drug-delivery System Product Overview
Table 138. Nikko Chemicals Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Nikko Chemicals Business Overview
Table 140. Nikko Chemicals Recent Developments
Table 141. Global Liposomal Drug-delivery System Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Liposomal Drug-delivery System Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Liposomal Drug-delivery System Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Liposomal Drug-delivery System Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Liposomal Drug-delivery System Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Liposomal Drug-delivery System Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Liposomal Drug-delivery System Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Liposomal Drug-delivery System Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Liposomal Drug-delivery System Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Liposomal Drug-delivery System Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Liposomal Drug-delivery System Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Liposomal Drug-delivery System Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liposomal Drug-delivery System Market Size Comparison by Region (M USD)
Table 5. Global Liposomal Drug-delivery System Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Liposomal Drug-delivery System Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Liposomal Drug-delivery System Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Liposomal Drug-delivery System Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug-delivery System as of 2022)
Table 10. Global Market Liposomal Drug-delivery System Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Liposomal Drug-delivery System Sales Sites and Area Served
Table 12. Manufacturers Liposomal Drug-delivery System Product Type
Table 13. Global Liposomal Drug-delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Liposomal Drug-delivery System
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Liposomal Drug-delivery System Market Challenges
Table 22. Global Liposomal Drug-delivery System Sales by Type (Kilotons)
Table 23. Global Liposomal Drug-delivery System Market Size by Type (M USD)
Table 24. Global Liposomal Drug-delivery System Sales (Kilotons) by Type (2019-2024)
Table 25. Global Liposomal Drug-delivery System Sales Market Share by Type (2019-2024)
Table 26. Global Liposomal Drug-delivery System Market Size (M USD) by Type (2019-2024)
Table 27. Global Liposomal Drug-delivery System Market Size Share by Type (2019-2024)
Table 28. Global Liposomal Drug-delivery System Price (USD/Ton) by Type (2019-2024)
Table 29. Global Liposomal Drug-delivery System Sales (Kilotons) by Application
Table 30. Global Liposomal Drug-delivery System Market Size by Application
Table 31. Global Liposomal Drug-delivery System Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Liposomal Drug-delivery System Sales Market Share by Application (2019-2024)
Table 33. Global Liposomal Drug-delivery System Sales by Application (2019-2024) & (M USD)
Table 34. Global Liposomal Drug-delivery System Market Share by Application (2019-2024)
Table 35. Global Liposomal Drug-delivery System Sales Growth Rate by Application (2019-2024)
Table 36. Global Liposomal Drug-delivery System Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Liposomal Drug-delivery System Sales Market Share by Region (2019-2024)
Table 38. North America Liposomal Drug-delivery System Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Liposomal Drug-delivery System Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Liposomal Drug-delivery System Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Liposomal Drug-delivery System Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Liposomal Drug-delivery System Sales by Region (2019-2024) & (Kilotons)
Table 43. Lipoid Kosmetik Liposomal Drug-delivery System Basic Information
Table 44. Lipoid Kosmetik Liposomal Drug-delivery System Product Overview
Table 45. Lipoid Kosmetik Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Lipoid Kosmetik Business Overview
Table 47. Lipoid Kosmetik Liposomal Drug-delivery System SWOT Analysis
Table 48. Lipoid Kosmetik Recent Developments
Table 49. Lucas Meyer Cosmetics Liposomal Drug-delivery System Basic Information
Table 50. Lucas Meyer Cosmetics Liposomal Drug-delivery System Product Overview
Table 51. Lucas Meyer Cosmetics Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Lucas Meyer Cosmetics Business Overview
Table 53. Lucas Meyer Cosmetics Liposomal Drug-delivery System SWOT Analysis
Table 54. Lucas Meyer Cosmetics Recent Developments
Table 55. Nippon Fine Chemical Liposomal Drug-delivery System Basic Information
Table 56. Nippon Fine Chemical Liposomal Drug-delivery System Product Overview
Table 57. Nippon Fine Chemical Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Nippon Fine Chemical Liposomal Drug-delivery System SWOT Analysis
Table 59. Nippon Fine Chemical Business Overview
Table 60. Nippon Fine Chemical Recent Developments
Table 61. Enoc Solutions Liposomal Drug-delivery System Basic Information
Table 62. Enoc Solutions Liposomal Drug-delivery System Product Overview
Table 63. Enoc Solutions Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Enoc Solutions Business Overview
Table 65. Enoc Solutions Recent Developments
Table 66. Nanovec Liposomal Drug-delivery System Basic Information
Table 67. Nanovec Liposomal Drug-delivery System Product Overview
Table 68. Nanovec Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Nanovec Business Overview
Table 70. Nanovec Recent Developments
Table 71. Lipotec Liposomal Drug-delivery System Basic Information
Table 72. Lipotec Liposomal Drug-delivery System Product Overview
Table 73. Lipotec Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Lipotec Business Overview
Table 75. Lipotec Recent Developments
Table 76. Croda Liposomal Drug-delivery System Basic Information
Table 77. Croda Liposomal Drug-delivery System Product Overview
Table 78. Croda Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Croda Business Overview
Table 80. Croda Recent Developments
Table 81. HandA Pharmachem Liposomal Drug-delivery System Basic Information
Table 82. HandA Pharmachem Liposomal Drug-delivery System Product Overview
Table 83. HandA Pharmachem Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. HandA Pharmachem Business Overview
Table 85. HandA Pharmachem Recent Developments
Table 86. Lipomize Liposomal Drug-delivery System Basic Information
Table 87. Lipomize Liposomal Drug-delivery System Product Overview
Table 88. Lipomize Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lipomize Business Overview
Table 90. Lipomize Recent Developments
Table 91. ID bio Liposomal Drug-delivery System Basic Information
Table 92. ID bio Liposomal Drug-delivery System Product Overview
Table 93. ID bio Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. ID bio Business Overview
Table 95. ID bio Recent Developments
Table 96. BioSpectrum Liposomal Drug-delivery System Basic Information
Table 97. BioSpectrum Liposomal Drug-delivery System Product Overview
Table 98. BioSpectrum Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. BioSpectrum Business Overview
Table 100. BioSpectrum Recent Developments
Table 101. Derma Clinical Liposomal Drug-delivery System Basic Information
Table 102. Derma Clinical Liposomal Drug-delivery System Product Overview
Table 103. Derma Clinical Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Derma Clinical Business Overview
Table 105. Derma Clinical Recent Developments
Table 106. Kewpie Corporation Liposomal Drug-delivery System Basic Information
Table 107. Kewpie Corporation Liposomal Drug-delivery System Product Overview
Table 108. Kewpie Corporation Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Kewpie Corporation Business Overview
Table 110. Kewpie Corporation Recent Developments
Table 111. Nanohealth Biotech Liposomal Drug-delivery System Basic Information
Table 112. Nanohealth Biotech Liposomal Drug-delivery System Product Overview
Table 113. Nanohealth Biotech Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Nanohealth Biotech Business Overview
Table 115. Nanohealth Biotech Recent Developments
Table 116. Creative Biostructure Liposomal Drug-delivery System Basic Information
Table 117. Creative Biostructure Liposomal Drug-delivery System Product Overview
Table 118. Creative Biostructure Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Creative Biostructure Business Overview
Table 120. Creative Biostructure Recent Developments
Table 121. Phenbiox Liposomal Drug-delivery System Basic Information
Table 122. Phenbiox Liposomal Drug-delivery System Product Overview
Table 123. Phenbiox Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Phenbiox Business Overview
Table 125. Phenbiox Recent Developments
Table 126. NOF CORPORATION Liposomal Drug-delivery System Basic Information
Table 127. NOF CORPORATION Liposomal Drug-delivery System Product Overview
Table 128. NOF CORPORATION Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. NOF CORPORATION Business Overview
Table 130. NOF CORPORATION Recent Developments
Table 131. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Basic Information
Table 132. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product Overview
Table 133. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. KYOWA PHARMA CHEMICAL Business Overview
Table 135. KYOWA PHARMA CHEMICAL Recent Developments
Table 136. Nikko Chemicals Liposomal Drug-delivery System Basic Information
Table 137. Nikko Chemicals Liposomal Drug-delivery System Product Overview
Table 138. Nikko Chemicals Liposomal Drug-delivery System Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Nikko Chemicals Business Overview
Table 140. Nikko Chemicals Recent Developments
Table 141. Global Liposomal Drug-delivery System Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Liposomal Drug-delivery System Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Liposomal Drug-delivery System Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Liposomal Drug-delivery System Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Liposomal Drug-delivery System Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Liposomal Drug-delivery System Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Liposomal Drug-delivery System Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Liposomal Drug-delivery System Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Liposomal Drug-delivery System Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Liposomal Drug-delivery System Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Liposomal Drug-delivery System Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Liposomal Drug-delivery System Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Liposomal Drug-delivery System Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Liposomal Drug-delivery System Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Liposomal Drug-delivery System
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liposomal Drug-delivery System Market Size (M USD), 2019-2030
Figure 5. Global Liposomal Drug-delivery System Market Size (M USD) (2019-2030)
Figure 6. Global Liposomal Drug-delivery System Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liposomal Drug-delivery System Market Size by Country (M USD)
Figure 11. Liposomal Drug-delivery System Sales Share by Manufacturers in 2023
Figure 12. Global Liposomal Drug-delivery System Revenue Share by Manufacturers in 2023
Figure 13. Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Liposomal Drug-delivery System Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Liposomal Drug-delivery System Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Liposomal Drug-delivery System Market Share by Type
Figure 18. Sales Market Share of Liposomal Drug-delivery System by Type (2019-2024)
Figure 19. Sales Market Share of Liposomal Drug-delivery System by Type in 2023
Figure 20. Market Size Share of Liposomal Drug-delivery System by Type (2019-2024)
Figure 21. Market Size Market Share of Liposomal Drug-delivery System by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Liposomal Drug-delivery System Market Share by Application
Figure 24. Global Liposomal Drug-delivery System Sales Market Share by Application (2019-2024)
Figure 25. Global Liposomal Drug-delivery System Sales Market Share by Application in 2023
Figure 26. Global Liposomal Drug-delivery System Market Share by Application (2019-2024)
Figure 27. Global Liposomal Drug-delivery System Market Share by Application in 2023
Figure 28. Global Liposomal Drug-delivery System Sales Growth Rate by Application (2019-2024)
Figure 29. Global Liposomal Drug-delivery System Sales Market Share by Region (2019-2024)
Figure 30. North America Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Liposomal Drug-delivery System Sales Market Share by Country in 2023
Figure 32. U.S. Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Liposomal Drug-delivery System Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Liposomal Drug-delivery System Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Liposomal Drug-delivery System Sales Market Share by Country in 2023
Figure 37. Germany Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Liposomal Drug-delivery System Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Liposomal Drug-delivery System Sales Market Share by Region in 2023
Figure 44. China Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Liposomal Drug-delivery System Sales and Growth Rate (Kilotons)
Figure 50. South America Liposomal Drug-delivery System Sales Market Share by Country in 2023
Figure 51. Brazil Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Liposomal Drug-delivery System Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Liposomal Drug-delivery System Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Liposomal Drug-delivery System Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Liposomal Drug-delivery System Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Liposomal Drug-delivery System Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Liposomal Drug-delivery System Market Share Forecast by Type (2025-2030)
Figure 65. Global Liposomal Drug-delivery System Sales Forecast by Application (2025-2030)
Figure 66. Global Liposomal Drug-delivery System Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Liposomal Drug-delivery System
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liposomal Drug-delivery System Market Size (M USD), 2019-2030
Figure 5. Global Liposomal Drug-delivery System Market Size (M USD) (2019-2030)
Figure 6. Global Liposomal Drug-delivery System Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liposomal Drug-delivery System Market Size by Country (M USD)
Figure 11. Liposomal Drug-delivery System Sales Share by Manufacturers in 2023
Figure 12. Global Liposomal Drug-delivery System Revenue Share by Manufacturers in 2023
Figure 13. Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Liposomal Drug-delivery System Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Liposomal Drug-delivery System Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Liposomal Drug-delivery System Market Share by Type
Figure 18. Sales Market Share of Liposomal Drug-delivery System by Type (2019-2024)
Figure 19. Sales Market Share of Liposomal Drug-delivery System by Type in 2023
Figure 20. Market Size Share of Liposomal Drug-delivery System by Type (2019-2024)
Figure 21. Market Size Market Share of Liposomal Drug-delivery System by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Liposomal Drug-delivery System Market Share by Application
Figure 24. Global Liposomal Drug-delivery System Sales Market Share by Application (2019-2024)
Figure 25. Global Liposomal Drug-delivery System Sales Market Share by Application in 2023
Figure 26. Global Liposomal Drug-delivery System Market Share by Application (2019-2024)
Figure 27. Global Liposomal Drug-delivery System Market Share by Application in 2023
Figure 28. Global Liposomal Drug-delivery System Sales Growth Rate by Application (2019-2024)
Figure 29. Global Liposomal Drug-delivery System Sales Market Share by Region (2019-2024)
Figure 30. North America Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Liposomal Drug-delivery System Sales Market Share by Country in 2023
Figure 32. U.S. Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Liposomal Drug-delivery System Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Liposomal Drug-delivery System Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Liposomal Drug-delivery System Sales Market Share by Country in 2023
Figure 37. Germany Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Liposomal Drug-delivery System Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Liposomal Drug-delivery System Sales Market Share by Region in 2023
Figure 44. China Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Liposomal Drug-delivery System Sales and Growth Rate (Kilotons)
Figure 50. South America Liposomal Drug-delivery System Sales Market Share by Country in 2023
Figure 51. Brazil Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Liposomal Drug-delivery System Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Liposomal Drug-delivery System Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Liposomal Drug-delivery System Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Liposomal Drug-delivery System Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Liposomal Drug-delivery System Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Liposomal Drug-delivery System Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Liposomal Drug-delivery System Market Share Forecast by Type (2025-2030)
Figure 65. Global Liposomal Drug-delivery System Sales Forecast by Application (2025-2030)
Figure 66. Global Liposomal Drug-delivery System Market Share Forecast by Application (2025-2030)
